Information from the 2018-2020 China Big Health Industry Investment Research Report:
The medical imaging industry is mainly divided into upstream medical imaging equipment and consumables and downstream diagnostic imaging services. Medical imaging is also one of the top segments in the scale of global medical devices.In 2012, the global medical device market sales amounted to USD 349 billion, of which the diagnostic imaging products market sales amounted to USD 36.1 billion, ranking No.3 in the global medical device market with a market share of 10.3%.
Medical imaging is also one of the largest medical device industries in the world. China is the fourth largest medical imaging market in the world, accounting for 12% of the global share.
Innovative imaging equipment sub-industry investment direction:
For general-purpose large-scale equipment, such as CT, magnetic **** vibration, PET-CT and other areas, there are fewer excellent early-stage projects at present, and the valuation is high. We are more optimistic about imaging equipment in niche areas, especially those with their own application scenarios of unique hardware and artificial intelligence algorithms, such as breast cancer ultrasound, dental cone beam CT and other directions. In addition, we are also more optimistic about the mastery of core technology and other imaging core components upstream enterprises.
In-vitro diagnostic sub-sector
Information on 2018-2020 China's Great Health Industry Investment Research Report:
In-vitro diagnostic reagents include blood, biochemistry, immunity, molecular biology, bacteria, POCT and other major aspects. China's in vitro diagnostic reagent industry has already had a certain market scale and foundation, and is stepping into the growth period from the industry's introduction period, with better market prospects.
According to statistics, in 2014-2015, the transaction size of 50 million U.S. dollars in medical device-related investment and mergers and acquisitions, involving in vitro diagnostics accounted for 1/3. 2016, China's in vitro diagnostics market size of about 51 billion yuan, is expected to maintain a 15-20% growth rate in the next 3-5 years, and the market size in 2020 will be more than 85 billion.
Compared with mature foreign markets, the scale of China's in vitro diagnostic reagent industry is still relatively small. China's population accounts for more than 1/5 of the world's population, but the share of the field of in vitro diagnostic reagents only accounted for 4% of the world's per capita annual use of in vitro diagnostic products in China is 1.5 U.S. dollars, while the per capita use of developed countries is 25 to 30 U.S. dollars. The overall development of China's in vitro diagnostic reagent industry is characterized by a large market, but the market potential is even greater. Therefore, in vitro diagnostic reagents are a hot piece of investment and financing in the medical device industry.